Mel Sorensen

Mel Sorensen appears in our data through filings on Galera Therapeutics, Inc. shares, published by SEC (Form 4). Between 26 March 2021 and 3 August 2026, the trades on record add up to 6 filings.

Market trades split into 1 purchase (€159k) and 2 sales (€5,617). Netting one side against the other leaves €153k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 option exercises.

Most recently, on 5 August 2026, the filings show a transaction in Galera Therapeutics, Inc. The last insider purchase was made public on 14 March 2023, 1,320 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.